Role of heparan sulfate in human parainfluenza virus type 3 infection

Virology

Volumn 298, Issue 1, 2002, Pages 73-83

  Bose, Santanu ^a   Banerjee, Amiya K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cellular entry; Heparan sulfate; Human parainfluenza virus type 3

Indexed keywords

HEPARAN SULFATE; HEPARIN LYASE; PROTEOGLYCAN; SODIUM CHLORATE;

ARTICLE; CELL SURFACE; CHO CELL; CONTROLLED STUDY; IN VITRO STUDY; INCUBATION TIME; INTERNALIZATION; LUNG ALVEOLUS CELL; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; RNA VIRUS INFECTION; SULFATION;

HUMAN PARAINFLUENZA VIRUS 3;

EID: 0036306741     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1484     Document Type: Article

References (59)

1. Virus-receptor interactions of human parainfluenza viruses type 1, 2 and 3
2. Serum amyloid P component binds to influenza A virus hemagglutinin and inhibits virus infection in vitro
3. Chlorate - A potent inhibitor of protein sulfation in intact cells
4. Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus
5. Polarity of human parainfluenza virus type 3 infection in polarized human lung epithelial A549 cells: Role of microfilament and microtubule
6. Molecular modeling of protein-glycosaminoglycan interactions
7. Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in Paramyxovirus fusion glycoproteins
8. Dengue virus infectivity depends on envelope protein binding to target cell heparin sulfate
9. Interferon action against human parainfluenza virus type 3: Involvement of a novel antiviral pathway in the inhibition of transcription
10. The paramyxovirus
11. Early interactions of human herpesvirus 6 with lymphoid cells: Role of membrane protein components and glycosaminoglycans in virus binding
12. Role of cellular actin in human parainfluenza virus type 3 genome transcription
13. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5
14. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2 host-cell interactions
15. Specificity studies on the heparin lysasa from Flavobacterium heparinum
16. Characterization of a 100 kilodalton binding protein for the six serotypes of Coxsackie B viruses
17. Recovery of infectious human parainfluenza virus type 3 from cDNA
18. Replica plating and in situ enzymatic assay of animal cell colonies established on filter paper
19. Animal cell mutants defective in glycosaminoglycan biosynthesis
20. The role of glycosaminoglycan binding of staphylococci in attachment to eukaryotic host cells
21. Adenosine triphosphate sulfurylase from Penicillium chrysogenum: Equilibrium binding, substrate hydrolysis, and isotope exchange studies
22. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate
23. Human papilloma virus infection requires cell surface heparan sulfate
24. Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment glycoprotein
25. The anti-influenza virus agent 4-GU-DANA (Zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA
26. Iduronic acid containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection
27. Glycosaminoglycan sulfation requirement for respiratory syncytial virus infection
28. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding
29. An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment receptor
30. Biological activity of Paramyxovirus fusion proteins: Factors influencing formation of syncytia
31. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses
32. Chlorate: A reversible inhibitor of proteoglycan sulfation
33. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes
34. Efficient infection of cells in culture by type O foot and mouth disease virus requires binding to cell surface heparan sulfate
35. Adaption of Sindbis virus to BHK cells selects for use of heparin sulfate as an attachment receptor
36. Heparin dependent attachment of respiratory syncytial virus (RSV) to host cells
37. Paramyxoviridae: The viruses and their replication
38. Cell membrane bound N-acetylneuraminic acid is involved in the infection of fibroblasts and phorbol ester differentiated monocyte-like cells with human cytomegalovirus (HCMV)
39. Structure, function, and intracellular processing of the glycoproteins of Paramyxoviridae
40. Fusion properties of cells persistently infected with human parainfluenza virus type 3: Participation of hemagglutinin-neuraminidase in membrane fusion
41. Fusion properties of cells infected with human parainfluenza virus type 3: Receptor requirements for viral spread and virus mediated membrane fusion
42. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic-acid correlates with virus-induced fusion activity
43. Analysis of human parainfluenza virus type 3 receptor binding variants: Evidence for the use of a specific sialic-acid containing receptor
44. The anti-HIV pseudopeptide HB-19 forms a complex with the cell surface expressed nucleolin independent of heparan sulfate proteoglycans
45. Effect of anionic polymers on fusion of Sendai virus with human erythrocyte ghosts
46. A RhoA derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3
47. Expression at the cell surface of biologically active fusion and hemagglutinin-neuraminidase proteins of the Paramyxovirus simian virus 5 from cloned cDNA
48. Analysis of the relationship between cleavability of a Paramyxovirus fusion protein and length of the connecting peptide
49. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3
50. Synthesis and sorting of proteoglycans
51. The interaction of heparin sulfate and adeno-associated virus 2
52. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp 120-gp 41
53. Selective effects of sodium chlorate treatment on the sulfation of heparin sulfate
54. Molecular dissection of nucleolin's role in growth and cell proliferation: New insights
55. Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection
56. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
57. Association of parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces
58. Activation of paracrine growth factors by heparan sulfate induced by glucocorticoid in A549 lung carcinoma cells
59. Effect of glycosaminoglycans and PEG on fusion of Sendai virus with phosphatidylserine vesicles